Whittington, Melanie D.
Mattingly, T. Joseph
Funding for this research was provided by:
No Patient Left Behind
Article History
Accepted: 5 November 2024
First Online: 27 November 2024
Declarations
:
: This study was funded by No Patient Left Behind. We thank No Patient Left Behind for their support in the study design and review of this manuscript. The study sponsor was not involved in data analysis.
: M.D.W. is a member of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center. The Center receives funding from government, private foundations, and pharmaceutical industry sources. M.D.W. also reports funding from the Institute for Clinical and Economic Review, National Pharmaceutical Council, National Health Council, and Genentech unrelated to this manuscript. M.D.W. is an editorial board member of Applied Health Economics and Health Policy. M.D.W. was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. T.J.M. reports research support from the Alzheimer’s Association and personal consulting from Arnold Ventures, Pharmaceutical Care Management Association, and Pharmaceutical Research and Manufacturers of America unrelated to this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: All data are publicly available.
: By request.
: Study design (M.D.W. and T.J.M.), stakeholder engagement (M.D.W.), review of literature and financial statements (T.J.M.), data validation (M.D.W. and T.J.M.), data analysis (M.D.W.), data interpretation (M.D.W. and T.J.M.), and manuscript writing (M.D.W. and T.J.M.)